Life Technologies Inc said ithas submitted to the Food and Drug Administration a new testwhich has proven effective in detecting a sexually transmittedvirus thought to play a role in the development of cervicalcancer.    Life Technologies said the test, called "ViraPap,"identifies the presence of human papillomavirus (HPV) bydetecting the virus' DNA makeup.    Life Technologies said the test uses radioactive probes toto detect the virus.  Reuter&#3;